Luigi Muratori

Author PubWeight™ 44.21‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet 2010 3.15
2 Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. Am J Gastroenterol 2003 2.69
3 Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C. Clin Infect Dis 2005 1.83
4 The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome. Am J Gastroenterol 2009 1.70
5 Non-organ-specific autoantibodies in children with chronic hepatitis C: clinical significance and impact on interferon treatment. Clin Infect Dis 2003 1.65
6 Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology 2008 1.40
7 Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis. Eur J Gastroenterol Hepatol 2014 1.40
8 Celiac disease in autoimmune cholestatic liver disorders. Am J Gastroenterol 2002 1.23
9 A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis. Hepatology 2010 1.10
10 Genetic distinctions between autoimmune hepatitis in Italy and North America. World J Gastroenterol 2005 0.95
11 Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease. J Immunol 2003 0.95
12 PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis. Am J Gastroenterol 2009 0.93
13 Smooth muscle antibodies and type 1 autoimmune hepatitis. Autoimmunity 2002 0.91
14 Hepatitis C virus infection associated with liver-kidney microsomal antibody type 1 (LKM1) autoantibodies in children. J Pediatr 2003 0.89
15 Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases. Eur J Gastroenterol Hepatol 2012 0.86
16 Autoimmune hepatitis in Italy: the Bologna experience. J Hepatol 2009 0.85
17 Antinuclear antibodies as ancillary markers in primary biliary cirrhosis. Expert Rev Mol Diagn 2012 0.85
18 Key residues of a major cytochrome P4502D6 epitope are located on the surface of the molecule. J Immunol 2002 0.84
19 Redistribution of regulatory T-cells across the evolving stages of chronic hepatitis C. Dig Liver Dis 2011 0.83
20 Autoimmune liver disease and concomitant extrahepatic autoimmune disease. Eur J Gastroenterol Hepatol 2015 0.83
21 Autoimmune liver disease 2007. Mol Aspects Med 2007 0.83
22 Enhanced monocyte Th1 cytokine production in HCV-infected cryoglobulinemic patients. J Hepatol 2003 0.82
23 Identification of new autoantigens by protein array indicates a role for IL4 neutralization in autoimmune hepatitis. Mol Cell Proteomics 2012 0.82
24 Antibodies to soluble liver antigen in patients with various liver diseases: a multicentre study. Liver Int 2013 0.81
25 Antitransglutaminase antibodies and giardiasis. Am J Gastroenterol 2004 0.81
26 Fatigue and pruritus at onset identify a more aggressive subset of primary biliary cirrhosis. Liver Int 2014 0.81
27 Immunoglobulin GM and KM allotypes and prevalence of anti-LKM1 autoantibodies in patients with hepatitis C virus infection. J Virol 2006 0.81
28 Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis. Liver Int 2004 0.81
29 Sex differences associated with primary biliary cirrhosis. Clin Dev Immunol 2012 0.80
30 Application of the 2010 American Association for the study of liver diseases criteria of remission to a cohort of Italian patients with autoimmune hepatitis. Hepatology 2010 0.80
31 Smoking as a risk factor for autoimmune liver disease: what we can learn from primary biliary cirrhosis. Ann Hepatol 2011 0.80
32 Acute icteric hepatitis induced by a short course of low-dose cyclophosphamide in a patient with lupus nephritis. Dig Dis Sci 2005 0.80
33 Autoantibody appearance in cytomegalovirus-infected liver transplant recipients: correlation with antigenemia. J Med Virol 2002 0.79
34 Clinical features and effect of antiviral therapy on anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis C. J Hepatol 2009 0.78
35 Hepatitis C and autoreactivity. Dig Liver Dis 2007 0.78
36 Autoantibodies in Autoimmune Hepatitis. Dig Dis 2015 0.78
37 Clinical and serological profile of primary biliary cirrhosis in young and elderly patients. QJM 2008 0.77
38 Multiple nuclear dots and rim-like/membranous IgG isotypes in primary biliary cirrhosis. Autoimmunity 2009 0.77
39 Antifilamentous actin antibodies by ELISA for the diagnosis of type 1 autoimmune hepatitis. Am J Gastroenterol 2007 0.76
40 Validation of simplified diagnostic criteria for autoimmune hepatitis in Italian patients. Hepatology 2009 0.76
41 Serum antibody reactivity to human intracisternal A-type particle retrovirus proteins in systemic sclerosis patients. Acta Derm Venereol 2004 0.76
42 LKM1-positive type 2 autoimmune hepatitis following allogenic hematopoietic stem-cell transplantation. Am J Gastroenterol 2008 0.75
43 Diagnostic difficulties, therapeutic strategies, and performance of scoring systems in patients with autoimmune hepatitis and concurrent hepatitis B/C. Scand J Gastroenterol 2013 0.75
44 Regulatory T cell defects in adult autoimmune hepatitis. J Hepatol 2012 0.75
45 Evidence of a genetic basis for the different geographic occurrences of liver/kidney microsomal antibody type 1 in hepatitis C. Dig Dis Sci 2006 0.75
46 New autoantibodies and autoantigens in autoimmune hepatitis. Clin Liver Dis 2002 0.75
47 [Significance of non-organ-specific autoantibodies in HCV-related chronic hepatitis]. Recenti Prog Med 2005 0.75
48 Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre study. Eur J Gastroenterol Hepatol 2017 0.75
49 Diagnosis and therapy of autoimmune hepatitis. Mini Rev Med Chem 2009 0.75